Continuous Glucose Monitoring Impact and Implications of Real-World Evidence: Past, Present, and Future

Abstract

Randomized controlled trials (RCTs), which are are considered the highest level of scientific evident, have shown significant glycemic benefits associated with use of continuous glucose monitoring (CGM) in individuals with diabetes who are treated with intensive insulin regimens.However, numerous prospective, retrospective, and observational studies have investigated the impact of CGM in various diabetes populations treated witn non-intensive therapies. Results from these studies have contributed to changes in payer coverage, prescriber behaviors and expanding use of CGM. This article reviews findings from recent real-world studies, highlight the key lessons learned from these studies, and discuss how we need to move forward in increasing utilization of and access to CGM among all diabetes patients who would benefit from this technology.

Measures of nutrition status and health for weight‐inclusive patient care: A narrative review

“…There is a call to expand insurance coverage to other groups of patients, including those with prediabetes. [120][121][122] If patients are willing and able to pay out of pocket for CGM supplies, the clinician should consider recommending using CGM at least for a limited duration in a prediabetes population. The rationale is that, with regular monitoring of postprandial blood glucose, patients can better understand and visualize how various foods affect blood glucose control in hopes that patients will make dietary changes and prevent the onset of a diabetes diagnosis.…”